UroGen Pharma Ltd. - Common Stock (URGN)

CUSIP: M96088105

Q3 2021 13F Holders as of 30 Sep 2021

Holder snapshot 7 signals
Share change
+63,177
Put/Call ratio
96%
SEC-reported price per share
$16.82
Number of holders
88
Value change
+$1,235,828
Number of buys
36
Open additional details 1 more signal available
Number of sells
29
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
48,549,968

Security key

M96088105

Report period

Q3 2021

Institutions

88

Top holders

10

Ownership snapshot

Top reported holders of URGN - UroGen Pharma Ltd. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MENORA MIVTACHIM HOLDINGS...
Disclosed value leader
MENORA MIVTACHIM HOLDINGS...
Comparable rows
0/15
Latest evidence
30 Jun 2021
13F Highest disclosed value: $45,118,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

MENORA MIVTACHIM HOLDINGS LTD. has the largest disclosed position value at $45.12M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MENORA MIVTACHIM HOLDINGS LTD.'s linked filing trail.
Disclosed position value Top 5
MENORA MIVTACHIM HOLDINGS LTD. $45.12M
BlackRock Finance, Inc. $26.37M
WELLINGTON MANAGEMENT GROUP LLP $21.22M
CREDIT SUISSE AG/ $16.58M
ZEKE CAPITAL ADVISORS, LLC $11.04M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MENORA MIVTACHIM HOLDINGS LTD.
13F
Company
13F
—
denominator unverified
$45,118,000
2,954,699 shares
— 30 Jun 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$26,372,000
1,727,039 shares
— 30 Jun 2021
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$21,219,000
1,389,625 shares
— 30 Jun 2021
CREDIT SUISSE AG/
13F
Company
13F
—
denominator unverified
$16,581,000
1,085,868 shares
— 30 Jun 2021
ZEKE CAPITAL ADVISORS, LLC
13F
Company
13F
—
denominator unverified
$11,038,000
722,875 shares
— 30 Jun 2021
Migdal Insurance & Financial Holdings Ltd.
13F
Company
13F
—
denominator unverified
$10,663,000
698,302 shares
— 30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
88
Shares
14,085,432
Rows available
88
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
78
Q3 2021 holders
88
Holder diff
10
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .